Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Conditions:   Anal Cancer;   Anal Carcinoma;   Anal Cancer Stage III;   Anal Cancer Stage II Interventions:   Drug: Chemotherapy;   Radiation: Radiation;   Drug: PD-L1 Sponsor:   Goethe University Recruiting

Source: ClinicalTrials.gov - January 15, 2020 Category: Research Source Type: clinical trials